Navigation Links
Simbionix Increases Product Offerings for OB/GYN Physicians
Date:3/11/2009

CLEVELAND and ZURICH, Switzerland, March 11 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, and VirtaMed, a Swiss medical engineering company, announced today a global collaboration agreement. Simbionix will exclusively distribute, market, and provide service for the VirtaMed HystSim, an advanced virtual reality hysteroscopy simulator.

Simbionix already offers a wide spectrum of simulators for minimal invasive surgery. "This new agreement further expands our product offering," says Simbionix CEO Gary Zamler. "The addition of the HystSim simulator, along with our recently launched laparoscopic surgery module for gynecology, shows how seriously Simbionix is investing in women's healthcare issues".

Simbionix' President and founder, Mr. Ran Bronstein, adds: "Our simulation technology is definitely a revolution in the world of medical training and assessment. We are happy to be working together with VirtaMed, a company as committed to technology and simulation quality as we are. Simbionix will keep increasing its product offering to the medical community and bring quality and service to its customers and partners."

"VirtaMed is thrilled to be working together with Simbionix, the market leader in surgical simulation," adds VirtaMed CEO Stefan Tuchschmid. "Simbionix is a partner that will ensure the HystSim simulator is available globally. We truly appreciate Simbionix' commitment to provide the best possible training for surgeons in every field."

VirtaMed HystSim(TM) will be officially launched at the next ACOG (American College of Obstetricians and Gynecologists) annual clinical meeting held in Chicago on May 2nd.

Further information and product demonstrations are available from your local Simbionix sales representative and at http://www.simbionix.com.

About VirtaMed

VirtaMed is a Swiss based company with an interdisciplinary background in medicine and engineering. The HystSim(TM) system is the first VirtaMed product and provides instructional teaching and training of diagnostic and therapeutic hysteroscopy. VirtaMed's mission is to develop state-of-the-art training tools for endoscopic surgery of highest possible realism, all with the ultimate goal to improve the quality of patient care. Additional company information can be found at http://www.virtamed.com.

About Simbionix

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. Visit http://www.simbionix.com

    Contact:
    Inbal Mazor
    VP Marketing
    Simbionix
    inbal@simbionix.com
    Tel: +972-8-9211177



'/>"/>
SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
2. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
3. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
4. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
5. Simbionix Launches Innovative Patient-Specific Simulation
6. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
7. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
8. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
9. R&D Spending by U.S. Biopharmaceutical Companies Increases 3 Percent in 2008
10. Despite Economic Woes, Physician Compensation Increases
11. Gerresheimer Substantially Increases Quarterly Operating Profit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):